Yolanda Jerez

872 total citations
30 papers, 433 citations indexed

About

Yolanda Jerez is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Yolanda Jerez has authored 30 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 9 papers in Cancer Research. Recurrent topics in Yolanda Jerez's work include HER2/EGFR in Cancer Research (7 papers), Advanced Breast Cancer Therapies (6 papers) and BRCA gene mutations in cancer (6 papers). Yolanda Jerez is often cited by papers focused on HER2/EGFR in Cancer Research (7 papers), Advanced Breast Cancer Therapies (6 papers) and BRCA gene mutations in cancer (6 papers). Yolanda Jerez collaborates with scholars based in Spain, Peru and France. Yolanda Jerez's co-authors include Miguel Martín, Sara López‐Tarruella, Iván Márquez‐Rodas, Isabel Echavarría, Rubén Barakat, José Á. García-Sáenz, Robert U. Newton, Daniel A. Galvão, Javier Sampedro and Isabel Calvo and has published in prestigious journals such as Annals of Oncology, European Journal of Cancer and Drugs.

In The Last Decade

Yolanda Jerez

29 papers receiving 427 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yolanda Jerez Spain 12 297 123 105 83 53 30 433
Yoshie Hasegawa Japan 11 217 0.7× 66 0.5× 88 0.8× 93 1.1× 37 0.7× 51 394
Janine Lombard Australia 11 204 0.7× 88 0.7× 78 0.7× 64 0.8× 55 1.0× 38 395
Gholamreza Safaee Ardekani Canada 13 215 0.7× 302 2.5× 124 1.2× 81 1.0× 14 0.3× 18 554
Eirini Papadopoulou Greece 13 211 0.7× 209 1.7× 182 1.7× 144 1.7× 73 1.4× 43 535
Urve Kuusk Canada 11 263 0.9× 124 1.0× 131 1.2× 68 0.8× 39 0.7× 29 475
Constanza Maximiano Spain 10 232 0.8× 221 1.8× 96 0.9× 72 0.9× 42 0.8× 30 432
Maria Fragoso Portugal 12 328 1.1× 129 1.0× 68 0.6× 171 2.1× 32 0.6× 19 507
Byung Kyun Ko South Korea 15 141 0.5× 117 1.0× 127 1.2× 70 0.8× 47 0.9× 37 429
Saya Jacob United States 11 226 0.8× 89 0.7× 136 1.3× 116 1.4× 21 0.4× 27 363
A. Cardillo Italy 10 300 1.0× 71 0.6× 363 3.5× 81 1.0× 60 1.1× 23 532

Countries citing papers authored by Yolanda Jerez

Since Specialization
Citations

This map shows the geographic impact of Yolanda Jerez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yolanda Jerez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yolanda Jerez more than expected).

Fields of papers citing papers by Yolanda Jerez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yolanda Jerez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yolanda Jerez. The network helps show where Yolanda Jerez may publish in the future.

Co-authorship network of co-authors of Yolanda Jerez

This figure shows the co-authorship network connecting the top 25 collaborators of Yolanda Jerez. A scholar is included among the top collaborators of Yolanda Jerez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yolanda Jerez. Yolanda Jerez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Monte-Millán, Marı́a del, Yolanda Jerez, Marta Roche-Molina, et al.. (2022). 85P Correlation between nCOUNTER PAM-50 assay and three IHC-based surrogate intrinsic breast cancer subtype classifiers: A real-world study. Annals of Oncology. 33. S160–S161. 2 indexed citations
2.
3.
Picornell, Antoni C., Isabel Echavarría, Enrique L. Álvarez, et al.. (2019). Breast cancer PAM50 signature: correlation and concordance between RNA-Seq and digital multiplexed gene expression technologies in a triple negative breast cancer series. BMC Genomics. 20(1). 452–452. 36 indexed citations
4.
Jerez, Yolanda, et al.. (2019). Poly (ADP-ribose) Polymerase Inhibition in Patients with Breast Cancer and BRCA 1 and 2 Mutations. Drugs. 80(2). 131–146. 12 indexed citations
5.
García‐González, Xandra, Sara López‐Tarruella, María I. García, et al.. (2018). Severe toxicity to capecitabine due to a new variant at a donor splicing site in the dihydropyrimidine dehydrogenase <em>(DPYD)</em> gene. Cancer Management and Research. Volume 10. 4517–4522. 5 indexed citations
6.
Martín, Miguel, Sara López‐Tarruella, Antonio Casado, et al.. (2018). Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling. Breast Cancer Research and Treatment. 171(3). 627–634. 30 indexed citations
7.
8.
Echavarría, Isabel, Sara López‐Tarruella, Iván Márquez‐Rodas, Yolanda Jerez, & Miguel Martín. (2017). Neratinib for the treatment of HER2-positive early stage breast cancer. Expert Review of Anticancer Therapy. 17(8). 669–679. 23 indexed citations
9.
Calvo, Aitana, Sara López‐Tarruella, Rosa Álvarez, et al.. (2017). Validation of the Royal Marsden Hospital (RMH) prognostic score on an enriched early treatment line cohort for phase I trial patients. Annals of Oncology. 28. v135–v135.
10.
Echavarría, Isabel, Yolanda Jerez, Miguel Martín, & Sara López‐Tarruella. (2017). Incorporating CDK4/6 Inhibitors in the Treatment of Advanced Luminal Breast Cancer. Breast Care. 12(5). 296–302. 6 indexed citations
11.
Márquez‐Rodas, Iván, Sara López‐Tarruella, Rosa Álvarez, et al.. (2017). Safety and immunobiological activity of intratumoral (IT) double-stranded RNA (dsRNA) BO-112 in solid malignancies: First in human clinical trial. Annals of Oncology. 28. v612–v612. 1 indexed citations
12.
Picornell, Antoni C., Sara López‐Tarruella, Yolanda Jerez, et al.. (2017). Pathological response in a triple-negative breast cancer cohort treated with neoadjuvant carboplatin and docetaxel according to Lehmann’s refined classification (TNBCtype-4). Annals of Oncology. 28. v48–v48. 3 indexed citations
13.
Echavarría, Isabel, Coralia Bueno, Sara López‐Tarruella, et al.. (2016). Multicenter analysis of neoadjuvant docetaxel, carboplatin, and trastuzumab in HER2-positive breast cancer. Breast Cancer Research and Treatment. 162(1). 181–189. 11 indexed citations
14.
Martín, Miguel, Manuel Ruíz‐Borrego, José M. Pérez, et al.. (2016). A phase I study of sonidegib (S) in combination with docetaxel (D) in patients (pts) with triple negative (TN) advanced breast cancer (ABC): GEICAM/2012-12 (EDALINE study). Annals of Oncology. 27. vi87–vi87. 3 indexed citations
15.
Márquez‐Rodas, Iván, M.T. Sanz, Sònia Luque, et al.. (2016). Five Years of Multidisciplinary Care in Hereditary Cancer: Our Experience in a Spanish University Hospital. Oncology. 92(2). 68–74. 3 indexed citations
16.
González‐Rivera, Milagros, Sara López‐Tarruella, Yolanda Jerez, et al.. (2016). Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial. Breast Cancer Research and Treatment. 156(3). 507–515. 22 indexed citations
17.
Anguera, Geòrgia, Ariadna Tibau, Fernando Andrés‐Pretel, et al.. (2015). 1215 Role of cooperative groups and funding source in clinical studies that support approved therapy for breast cancer. European Journal of Cancer. 51. S176–S177. 1 indexed citations
18.
López‐Tarruella, Sara, Yolanda Jerez, Iván Márquez‐Rodas, et al.. (2015). Supervised physical exercise improves VO2max, quality of life, and health in early stage breast cancer patients: a randomized controlled trial. Breast Cancer Research and Treatment. 153(2). 371–382. 79 indexed citations
19.
Ramos‐Medina, Rocío, Fernando Moreno, Sara López‐Tarruella, et al.. (2015). Review: circulating tumor cells in the practice of breast cancer oncology. Clinical & Translational Oncology. 18(8). 749–759. 5 indexed citations
20.
Højman, Pernille, Iván Márquez‐Rodas, Sara López‐Tarruella, et al.. (2014). Running away from side effects: physical exercise as a complementary intervention for breast cancer patients. Clinical & Translational Oncology. 17(3). 180–196. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshie Hasegawa Breakdown of academic impact, for papers by Janine Lombard Breakdown of academic impact, for papers by Gholamreza Safaee Ardekani Breakdown of academic impact, for papers by Eirini Papadopoulou Breakdown of academic impact, for papers by Urve Kuusk Breakdown of academic impact, for papers by Constanza Maximiano Breakdown of academic impact, for papers by Maria Fragoso Breakdown of academic impact, for papers by Byung Kyun Ko Breakdown of academic impact, for papers by Saya Jacob Breakdown of academic impact, for papers by A. Cardillo
Rankless by CCL
2026